ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 137 filers reported holding ANAPTYSBIO INC in Q4 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,510 | -11.8% | 307 | 0.0% | 0.00% | – |
| Q2 2023 | $6,244 | -6.5% | 307 | 0.0% | 0.00% | – |
| Q1 2023 | $6,677 | -29.8% | 307 | 0.0% | 0.00% | – |
| Q4 2022 | $9,510 | +18.9% | 307 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | +33.3% | 307 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -25.0% | 307 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 307 | 0.0% | 0.00% | – |
| Q4 2021 | $11,000 | -91.9% | 307 | -95.1% | 0.00% | -100.0% |
| Q1 2021 | $136,000 | +0.7% | 6,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $135,000 | +45.2% | 6,300 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $93,000 | -34.0% | 6,300 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $141,000 | +58.4% | 6,300 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $89,000 | -50.0% | 6,300 | +23.9% | 0.00% | -40.0% |
| Q3 2019 | $178,000 | -16.4% | 5,085 | +35.0% | 0.01% | -16.7% |
| Q2 2019 | $213,000 | – | 3,768 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |